AstraZeneca offloads more Seroquel rights, this time to Cheplapharm for $42M

3rd December 2019 Uncategorised 0

AstraZeneca has raised billions on rights sales in recent years as it focuses on new launches. On Tuesday, the drugmaker continued the strategy through a $42 million deal on Seroquel and Seroquel XR with Cheplapharm. AZ just last month tied up with Cheplapharm on acid reflux med Losec.

More: AstraZeneca offloads more Seroquel rights, this time to Cheplapharm for M
Source: fierce